Earnings Call · Q2 FY2025·2025-08-14

Q2 25EPS +22.41%·Rev n/aQ1 25EPS +13.79%·Rev n/aQ4 24EPS -2.64%·Rev n/aQ3 24EPS +22.54%·Rev n/a⚠ consensus missing

Dare Bioscience, Inc. DARE

MarDee J. Haring-Layton — Chief Financial Officer

Sabrina Martucci Johnson — President

+6.3%1d on move date+6.5% vs SPY3d−2.4%5d+1.4%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more DARE calls or request research access.

More DARE calls Browse calls Request research access